FMC CORP (FMC)
NYSE · Chemicals · Chemicals & Allied Products
- Price
- $9.90
- Day
- -6.34%
- Market cap
- $1.24B
Close 2026-09-23.
The company
General FMC Corporation is a global agricultural sciences company dedicated to providing farmers with innovative solutions that increase the productivity and resilience of their land. We operate in a single distinct business segment. We develop, market and sell all three major classes of crop protection chemicals (insecticides, herbicides and fungicides) as well as biologicals, crop nutrition, and seed treatment products, which we group as plant health. FMC’s innovative crop protection solutions help growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC is committed to discovering new insecticide, herbicide, and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet.
From Item 1: General.
By product & service
- Insecticides — 45%
- Herbicides — 36%
- Fungicides — 10%
- Plant Health — 6%
- Product and Service Other — 3%
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- BlackRock, Inc. — $157.28M
- AQR CAPITAL MANAGEMENT LLC — $90.71M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $88.77M
- STATE STREET CORP — $75.36M
- VANGUARD CAPITAL MANAGEMENT LLC — $66.23M
- AMERICAN CENTURY COMPANIES INC — $58.12M
- BlackRock, Inc. — $48.63M
- D. E. Shaw & Co., Inc. — $33.88M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Pfeiffer Nicholas (Corporate Controller) sold 1,251 shares at $12.78 on 2026-09-09
- BARRY MICHAEL F (Director) bought 18,072 shares at $13.83 on 2026-03-04
- Raines John Mitchell (Director) bought 7,000 shares at $13.77 on 2025-11-13
- DAVIDSON CAROL ANTHONY (Director) bought 10,000 shares at $13.60 on 2025-11-05
- Scanlan Jacqueline (Executive VP & Chief HRO) sold 3,790 shares at $34.00 on 2025-09-29
- Scanlan Jacqueline (Executive VP & Chief HRO) sold 1,510 shares at $37.49 on 2025-08-18
Recent filings
- 8-K — 2026-09-23
- 4 — 2026-09-10
- 144 — 2026-09-09
- SCHEDULE 13G — 2026-08-07
- 10-Q — 2026-07-30
- 8-K — 2026-07-29
- SCHEDULE 13G/A — 2026-07-28
- 4 — 2026-07-17
- 4 — 2026-07-17
- 4 — 2026-07-17